Company profile
ViewRay, Inc.
OTC: VRAYQ · Healthcare · Medical - Devices
#349 of 1,418 Healthcare companies by revenuetop-quartile growth
EA Score
——FH —DQ 60GM —SS 48
v0.1 · 25/100 weight · pillars only
↑ revenue growth (YoY), workforce scale · ↓ market scale, Piotroski F
Methodology →Revenue TTM
$105.9M
Rev growth YoY (TTM)
+44.1%
Net income (FY)
-$107.3M
Employees
295
as of 2026-08-29
Market cap
$18.3k
as of 2026-08-29
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$102.2M$102.2M2022
Net income-$107.3M-$107.3M2022
Operating income-$107.1M-$107.1M2022
Total assets$271.4M$271.4M2022
Liabilities$189.2M$189.2M2022
Equity$82.2M$82.2M2022
Revenue trend
FY2015 – FY2022 · USD
FY15
FY18
FY18
FY18
FY19
FY20
FY21
FY22
Revenue by segment
Filed disclosures · FY2022
By product
Product78%
Service22%
Distribution Service1%
By geography
UNITED STATES51%
Rest Of World31%
ITALY10%
FRANCE7%
TAIWAN0%
The read
What is ViewRay, Inc.’s revenue?
ViewRay, Inc. booked $102.2M in FY2022 revenue, growing 46% year over year — faster than most Healthcare companies we track, at a -105.0% net margin.
Peers · Healthcare
Planet 13 Holdings Inc.44DSanara MedTech Inc.61CSutro Biopharma, Inc.47DStateHouse Holdings Inc.——Beta Bionics, Inc.58CNeuroPace, Inc.53DNeighbors
Cuyahoga →Key facts
CEOPaul Ziegler
SectorHealthcare
IndustryMedical - Devices
HeadquartersOakwood Village, OH
ExchangeOTC: VRAYQ
Employees295
IPO date2015-08-10
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.